Literature DB >> 7944300

Molecular genetic studies of muscle lactate dehydrogenase deficiency in white patients.

S Tsujino1, S Shanske, A K Brownell, R G Haller, S DiMauro.   

Abstract

We identified two new mutations in 2 white patients with muscle lactate dehydrogenase deficiency. Both patients had exercise intolerance, cramps, and recurrent myoglobinuria. One patient was homozygous for a 2-bp deletion in exon 5, resulting in a frameshift with premature termination of translation. The second patient was homozygous for a G-->A substitution at the 3' end of exon 2, leading to exon skipping and splicing of exon 1 to exon 3; the aberrantly spliced messenger RNA contains a frameshift, resulting in premature termination of translation. The present report provides evidence of molecular genetic heterogeneity in white patients with muscle lactate dehydrogenase deficiency.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  1994        PMID: 7944300     DOI: 10.1002/ana.410360418

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  8 in total

Review 1.  Metabolic Myoglobinuria.

Authors:  Emanuele Barca; Valentina Emmanuele; Salvatore Billi DiMauro
Journal:  Curr Neurol Neurosci Rep       Date:  2015-10       Impact factor: 5.081

Review 2.  Genomics and genetics in the biology of adaptation to exercise.

Authors:  Claude Bouchard; Tuomo Rankinen; James A Timmons
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

3.  Diagnostic evaluation of rhabdomyolysis.

Authors:  Jessica R Nance; Andrew L Mammen
Journal:  Muscle Nerve       Date:  2015-03-14       Impact factor: 3.217

4.  Specific Inhibition of Hepatic Lactate Dehydrogenase Reduces Oxalate Production in Mouse Models of Primary Hyperoxaluria.

Authors:  Chengjung Lai; Natalie Pursell; Jessica Gierut; Utsav Saxena; Wei Zhou; Michael Dills; Rohan Diwanji; Chaitali Dutta; Martin Koser; Naim Nazef; Rachel Storr; Boyoung Kim; Cristina Martin-Higueras; Eduardo Salido; Weimin Wang; Marc Abrams; Henryk Dudek; Bob D Brown
Journal:  Mol Ther       Date:  2018-06-15       Impact factor: 11.454

5.  Knockdown of lactate dehydrogenase by adeno-associated virus-delivered CRISPR/Cas9 system alleviates primary hyperoxaluria type 1.

Authors:  Rui Zheng; Xiaoliang Fang; Xi Chen; Yunteng Huang; Guofeng Xu; Lei He; Yueyan Li; Xuran Niu; Lei Yang; Liren Wang; Dali Li; Hongquan Geng
Journal:  Clin Transl Med       Date:  2020-12

6.  Hepatic Lactate Dehydrogenase A: An RNA Interference Target for the Treatment of All Known Types of Primary Hyperoxaluria.

Authors:  Gema Ariceta; Kelly Barrios; Bob D Brown; Bernd Hoppe; Ralf Rosskamp; Craig B Langman
Journal:  Kidney Int Rep       Date:  2021-02-03

Review 7.  Therapeutic RNA interference: A novel approach to the treatment of primary hyperoxaluria.

Authors:  Thomas A Forbes; Bob D Brown; Chengjung Lai
Journal:  Br J Clin Pharmacol       Date:  2021-06-11       Impact factor: 3.716

Review 8.  The Metabolic Fates of Pyruvate in Normal and Neoplastic Cells.

Authors:  Edward V Prochownik; Huabo Wang
Journal:  Cells       Date:  2021-03-30       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.